Cyclosporine and tacrolimus: Influence on cardiovascular risk factors

Transplantation Proceedings

Volumn 37, Issue 2, 2005, Pages 1036-1038

  Hohage, H ^a   Hillebrandt, U ^a   Welling, U ^a   Zeh, M ^a   Heck, M ^a   Gerhardt, U W ^a   Suwelack, B M ^a  

^a Nephrologisches Zentrum Emsland   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; TACROLIMUS;

ADULT; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONFERENCE PAPER; CONTROLLED STUDY; DATA ANALYSIS; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; KIDNEY FUNCTION; KIDNEY GRAFT; KIDNEY GRAFT REJECTION; MALE; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE; URIC ACID BLOOD LEVEL;

EID: 17844372765     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2004.12.031     Document Type: Conference Paper

References (10)

1. L.S. Ibels, J.H. Stewart, J.F. Mahony Deaths from occlusive arterial disease in renal allograft recipients Br Med J 3 1974 552
2. B.L. Kasiske Risk factors for accelerated atherosclerosis in renal transplant recipients Am J Med 84 1988 985
3. F.P. Brunner, M. Broyer, H. Brynger Survival on renal replacement therapy: data from EDTA registry Nephrol Dial Transplant 2 1988 109
4. F. Vincenti, S.C. Jensik, R.S. Filo A long-term comparison of tacrolimus (FK506) and cyclosporine in kidney transplantation: evidence for improved allograft survival at five years Transplantation 73 2002 775
5. M. Köhnle, U. Zimmermann, P. Lutkes Conversion from cyclosporine A to tacrolimus after kidney transplantation due to hyperlipidemia Transpl Int 13 suppl 1 2000 S345
6. R. Margreiter European Tacrolimus vs Ciclosporin Microemulsion Renal Transplantation Study Group: Efficacy and safety of tacrolimus compared with ciclosporin microemulsion in renal transplantation: a randomised multicentre study Lancet 359 2002 741
7. J. Radermacher, M. Meiners, C. Bramlage Pronounced renal vasoconstriction and systemic hypertension in renal transplant patients treated with cyclosporin A versus FK 506 Transpl Int 11 1998 3
8. M.A. Artz, J.M. Boots, G. Ligtenberg Improved cardiovascular risk profile and renal function in renal transplant patients after randomized conversion from cyclosporine to tacrolimus J Am Soc Nephrol 14 2003 1880
9. M. Pascual, T. Theruvath, T. Kawai Strategies to improve long-term outcomes after renal transplantation N Engl J Med 346 2002 580
10. K.M. Wissing, D. Abramowicz, N. Broeders Hypercholesterolemia is associated with increased kidney graft loss caused by chronic rejection in male patients with previous acute rejection Transplantation 70 2000 464